Eli Lilly China
Aboutthe company
Market position and key achievements
Eli Lilly China
Brief Description
Eli Lilly China — a division of the international pharmaceutical company Eli Lilly, one of the world's leading developers of medications for treating diabetes, oncological diseases, and autoimmune conditions. In China, the company actively invests in scientific research, clinical programs, and healthcare partnerships.
Main Products / Services and Key Markets
- Medications for diabetes treatment
- Innovative biopharmaceutical solutions
- Medical research, clinical programs, educational initiatives
- Key markets — medical institutions in China, pharmaceutical distributors, research centers
Year of Establishment, Scale, Presence
- Eli Lilly founded in 1876
- Present in China since the early 1990s
- R&D centers, production facilities, medical hubs, and scientific programs throughout the country
What Makes Their Exhibition Hall / Activities Interesting
- Demonstration of pharmaceutical solutions and innovations for diabetes therapy
- Understanding the scientific foundation behind new medications
- Overview of the company's strategies in prevention, control, and digital solutions for patients
- Integration of science, clinical practice, and technology
Visitprogramme
What the visit includes
Visit Program
09:00–10:00 Visit to the Eli Lilly exhibition hall — overview of innovations, diabetes solutions and scientific approaches
10:00–11:30 Thematic presentation: Eli Lilly — solutions in diabetology — modern medications, scientific technologies, patient condition management
Note: The presented program is a brief introductory description.
For more detailed content, please send us a message, and we will send you an extended version of the program.
Ready to visitEli Lilly China?
Send a request and we'll arrange an exclusive visit tailored to your needs